Several studies have suggested that neutralization of IL-6 attenuates murine colitis (40, 41), while Terabe et al. went further, demonstrating that neutralization of the IL-6 receptor specifically had stronger therapeutic efficacy than neutralization of TNF-α (42). The gene discussed is IL6; the disease is colitis.